<DOC>
	<DOCNO>NCT02335788</DOCNO>
	<brief_summary>This open label , acute , non-randomized , prospective , `` first man '' ( FIM ) single-center study EMBA Medical Peripheral Embolization Device ( PED ) .</brief_summary>
	<brief_title>EMBA Peripheral Embolization Device ( `` EPED '' ) Study</brief_title>
	<detailed_description>This study FIM , open label , prospective , single center , non-randomized , evaluation EMBA Medical Peripheral Embolization Device ( PED ) use arterial venous embolization peripheral vasculature .</detailed_description>
	<criteria>1 . The patient &gt; 18 year age . 2 . Patient consider candidate arterial venous embolization peripheral vasculature . 3 . Patient target vessel diameter 38mm target PED land zone great 25mm wherein vessel diameter 3 8 mm . 4 . The patient legal guardian inform nature study agree provision provide informed write consent . 5 . The patient suitable vessel anatomy would allow proper placement PED . 1 . The patient one follow condition : 1.1 Arteriovenous fistula 1.2 Hypercoagulability 1.3 Systemic coagulopathy 1.4 Connective tissue disorder EhlersDanlos Syndrome 1.5 Congenital arteritis Takayasu 's Disease 1.6 Other circulatory disorder discretion implant physician 2 . The patient uncontrolled infectious disease . 3 . The patient life expectancy le 6 month . 4 . The patient pregnant . 5 . The patient condition inhibits radiographic visualization PED . 6 . The patient know allergy intolerance Nitinol . 7 . The patient know hypersensitivity contrast pretreated . 8 . The patient 's access vessel preclude safe insertion delivery system . 9 . The patient currently participate another device drug study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Therapeutic</keyword>
	<keyword>Embolization</keyword>
</DOC>